Clinical Trials Browser

Withdrawn × Advanced Malignancies × cemiplimab × Clear all

NCT02520245 2016-11-07

Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study

Phase 1 Withdrawn

Advanced Malignancies